Quick Takeaways
- Paradigm Biocapital Advisors LP filed SCHEDULE 13G for Achieve Life Sciences, Inc. Common Stock, $0.001 par value per share (ACHV).
- Disclosed ownership: 9.2%.
- Date of event: 17 Apr 2026.
Paradigm Biocapital Advisors LP - 17 Apr 2026 SCHEDULE 13G Report for Achieve Life Sciences, Inc. Common Stock, $0.001 par value per share (ACHV)
- Filing Manager
- Paradigm Biocapital Advisors LP
- Reporting Manager
- Paradigm BioCapital Advisors LP
- Symbol
- ACHV
- Shares outstanding
- 107,649,043 shares
- Disclosed Ownership
- 9,903,712 shares
- Ownership
- 9.2%
- Form type
- SCHEDULE 13G
- Filing time
- 24 Apr 2026, 20:12:50 UTC
- Date of event
- 17 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Paradigm Biocapital Advisors LP disclosed 9.2% ownership in Achieve Life Sciences, Inc. Common Stock, $0.001 par value per share (ACHV) on 17 Apr 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 24 Apr 2026, 20:12.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Paradigm BioCapital Advisors LP | 9.2% | 9,903,712 | 9,903,712 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory | |
| Paradigm BioCapital Advisors GP LLC | 9.2% | 9,903,712 | 9,903,712 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory | |
| Senai Asefaw, M.D. | 9.2% | 9,903,712 | 9,903,712 | 0 | /s/ Senai Asefaw, M.D. | N/A | |
| Paradigm BioCapital International Fund Ltd. | 8.1% | 8,687,536 | 8,687,536 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory |